erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

phil lempert: it's affordability. it's convenience. it's not having a lot of waste. people are more concerned about waste than ever before...

when hard rains fall, the media are there with an umbrella to hold over organized society�s head. to walk away in the middle of a downpour would leave the status quo unprotected..